CORSINI, ALBERTO
CORSINI, ALBERTO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study
2024 M. Ruscica, C. Macchi, S. Gandini, D. Macis, A. Guerrieri-Gonzaga, V. Aristarco, D. Serrano, M. Lazzeroni, A.S. Rizzuto, A. Gaeta, A. Corsini, M. Gulisano, H. Johansson, B. Bonanni
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
2024 N. Ferri, M. Ruscica, S. Fazio, A. Corsini
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience
2023 P. Faggiano, M. Ruscica, S. Bettari, A. Cherubini, S. Carugo, A. Corsini, G. Barbati, A. Di Lenarda
Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect?
2023 N. Ferri, A. Corsini
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence
2023 C. Rossi, M. Venturin, J. Gubala, A. Frasca, A. Corsini, C. Battaglia, S. Bellosta
Fixed Combination for the Treatment of Dyslipidaemia
2023 N. Ferri, M. Ruscica, R.D. Santos, A. Corsini
Pollution from fine particulate matter and atherosclerosis: A narrative review
2023 C. Macchi, C.R. Sirtori, A. Corsini, P. Mannuccio Mannucci, M. Ruscica
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
2023 M. Ruscica, C. Macchi, A. Giuliani, A.S. Rizzuto, D. Ramini, M. Sbriscia, S. Carugo, A.R. Bonfigli, A. Corsini, F. Olivieri, J. Sabbatinelli
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
2023 S. Carugo, C.R. Sirtori, G. Gelpi, A. Corsini, L. Tokgozoglu, M. Ruscica
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
2023 N. Ferri, A. Corsini, M. Ruscica
Smooth Muscle Cell Phenotypic Switch Induced by Traditional Cigarette Smoke Condensate: A Holistic Overview
2023 L. Bianchi, I. Damiani, S. Castiglioni, A. Carleo, R. De Salvo, C. Rossi, A. Corsini, S. Bellosta
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
2023 E. Raschi, M. Casula, A.F.G. Cicero, A. Corsini, C. Borghi, A. Catapano
Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications
2022 M. Ruscica, N. Ferri, M. Banach, C.R. Sirtori, A. Corsini
Role of lipoprotein(a) in plaque progression
2022 M. Ruscica, A.S. Rizzuto, A. Corsini
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity
2022 C. Macchi, M.F. Greco, C. Favero, L. Dioni, L. Cantone, M. Hoxha, L. Vigna, G. Solazzo, A. Corsini, M. Banach, A.C. Pesatori, V. Bollati, M. Ruscica
Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells
2022 C. Macchi, M.F. Greco, N. Ferri, P. Magni, A. Arnoldi, A. Corsini, C.R. Sartori, M. Ruscica, C. Lammi
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals
2022 A. Poli, A.L. Catapano, A. Corsini, E. Manzato, J.P. Werba, G. Catena, I. Cetin, A.F.G. Cicero, A. Cignarella, F. Colivicchi, A. Consoli, F. Landi, M. Lucarelli, D. Manfellotto, W. Marrocco, D. Parretti, P. Perrone Filardi, A. Pirillo, G. Sesti, M. Volpe, F. Marangoni
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
2022 S. Carugo, C.R. Sirtori, A. Corsini, L. Tokgozoglu, M. Ruscica
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
2022 M. Vrablik, A. Corsini, E. Tůmová
The Role of High-Density Lipoprotein Cholesterol in 2022
2022 C.R. Sirtori, A. Corsini, M. Ruscica